Case Study: Treating HER2-Positive Metastatic Breast Cancer, Part II
In the continuation of a case-based discussion, the panel reviews clinical trials that explore potential treatment strategies for a 59 year-old woman with metastatic ...
OncLiveTV
Belgian Researchers Discover Way to Block Cancer Metastasis
Cancer remains one of the deadliest diseases, despite many new methods to combat it. Modern medicine has treatments to prevent the growth of primary tumor ...
VOA News
Options for Third-line Therapy in Metastatic CRC
Tanios Bekaii-Saab, MD, reviews the options for third-line therapy in a patient with metastatic colorectal cancer and, importantly, the toxicities that need to be ...
Targeted Oncology
Identifying a Novel Diagnostic and Therapeutic Target for Metastatic Breast Cancer
With metastasis posing the primary challenge in the clinical management of breast cancer, there is high demand for effective diagnostic and therapeutic ...
ACEA Biosciences - A part of Agilent
Case Review: Metastatic HCC and a History of HCV
Ghassan K. Abou-Alfa, MD, reviews the presentation and treatment approach of a 60-year-old man diagnosed with unresectable hepatocellular carcinoma ...
Targeted Oncology
Third-Line Therapy for Metastatic Colorectal Cancer
Edward Chu, MD, reviews the treatment options and associated toxicities for third-line therapy now that the patient has chemorefractory metastatic colorectal ...
Targeted Oncology
Metastatic Prostate Cancer: Intrinsic Genomic Subtypes
Joe O'Sullivan, MD, FRCPI, FFRRCSI, FRCR; Chris Parker, MD, FRCR, MRCP; Bertrand Tombal, MD, PhD; and Johann de Bono, PhD, MB, ChB, provide their ...
OncLiveTV
Impact of TAS-102 in metastatic colorectal cancer - Video Abstract ID 113320
Video abstract of review paper “Emerging combination therapies for metastatic colorectal cancer – impact of trifluridine/tipiracil” published in the open access ...
Dove Medical Press
Case 2: Cisplatin-Ineligible Metastatic Bladder Cancer
Arlene Siefker-Radtke, MD, reviews the case of a 68-year-old man with cisplatin-ineligible metastatic bladder cancer.
Targeted Oncology
Testing for NTRK Fusion–Positive Metastatic Colon Cancer
Preferred methods of testing for NTRK fusions and the significance of testing for MSI in the setting of NTRK fusion–positive mCRC. For more resources and ...
Targeted Oncology
Considerations When Selecting an EGFR Inhibitor in Metastatic Colorectal Cancer
Panelists discuss the results of the ASPECCT trial, which compared cetuximab with panitumumab in patients with metastatic colorectal cancer, and other ...
OncLiveTV
Early Lines of Therapy for HER2+ De Novo Metastatic Breast Cancer
Reshma L Mahtani, DO, reviews factors that influence first- and second-line treatment decisions for using the CLEOPATRA and EMILIA regimens in women with ...
Targeted Oncology
Introduction to Cancer Biology (Part 1): Abnormal Signal Transduction
This animation is the first part of the series "An Introduction to Cancer Biology", and explains the mechanism of abnormal signal transduction resulting in ...
Mechanisms in Medicine
Exploring MEDI0680/Durvalumab Versus Nivolumab in Metastatic ccRCC
Martin H. Voss, MD, medical oncologists, Memorial Sloan Kettering Cancer Center, reviews the method of design and results for the phase I/II study of the ...
Targeted Oncology
A 62-Year-Old Woman With BRAF V600E+ Metastatic NSCLC
Joshua Bauml, MD, reviews the case of a 62-year-old woman with BRAF V600E+ metastatic non–small cell lung cancer and the importance of molecular testing ...
Targeted Oncology
Systemic Treatment in Metastatic HCC
Ghassan K. Abou-Alfa, MD, reviews the details of a case of a 70-year-old man with metastatic hepatocellular carcinoma and provides his initial impressions.
Targeted Oncology
Case 4: Metastatic Colon Cancer, MSI-High
Shubham Pant, MD, remarks on microsatellite instability (MSI)–high metastatic colon cancer in a 43-year-old male and reviews clinical trials that have evaluated ...
Targeted Oncology
Drug development for metastatic castration-resistant prostate cancer
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Hilary Glen, MbChB, MSc, PhD, FRCP, of the Beatson West of Scotland ...
EMG-Health
Conclusion: Final Thoughts on Treating Metastatic Prostate Cancer
In the final clip of the discussion, panelists discusses the treatment of men with metastatic castration-resistant prostate cancer, as treatments continues to evolve ...
OncLiveTV
Case 1: BRAF-Mutated Metastatic Colorectal Cancer
Shubham Pant, MD, reviews the diagnostic workup of a 73-year-old man with BRAF-mutated metastatic colon cancer and comments on recent data. For more ...
Targeted Oncology
Dr. Randall Holcombe Discusses Regorafenib for Metastatic Colorectal Cancer
Randall F. Holcombe, MD, Associate Director for Clinical Affairs and Director of Gastrointestinal Medical Oncology for the Division of Hematology/Oncology at ...
OncLiveTV
TAS-102 in Refractory Metastatic Colorectal Cancer
In this segment, panelists discuss TAS-102 and the important role that fluoropyrimidines have across the entire treatment continuum for patients with metastatic ...
OncLiveTV
Sequencing Agents in Metastatic Colorectal Cancer
In this segment, Johanna Bendell, MD, and Manish Shah, MD, talk about sequencing therapies through multiple lines of therapy in patients with metastatic ...
OncLiveTV
Importance of biomarkers when evaluating heterogeneity in HER2+ metastatic BC
Maria Vittoria Dieci, MD, of the University of Padua, Padova, Italy, reviews how current biomarkers are used in the stratification of HER2+ metastatic breast ...
VJOncology
Dynamical systems biology of cancer metastasis by Mohit Kumar Jolly
DISCUSSION MEETING : MATHEMATICAL AND STATISTICAL EXPLORATIONS IN DISEASE MODELLING AND PUBLIC HEALTH ORGANIZERS : Nagasuma ...
International Centre for Theoretical Sciences
Tumor Ablation promotes Metastasis
1 https://www.youtube.com/results?search_query=zajicek+gershom+playlists ...
Gershom Zajicek M.D,
TKI Combinations in Metastatic EGFR+ Lung Cancer
Rebecca Heist, MD, reviews the data from the phase 3 NEJ026 trial of bevacizumab with erlotinib and the phase 3 RELAY study of ramucirumab with erlotinib for ...
OncLiveTV
TAS-102 in Metastatic Colorectal Cancer
Howard S. Hochster, MD; Richard L. Goldberg, MD; and Fadi Braiteh, MD, describe investigational compound, TAS-102, in the setting of metastatic colorectal ...
OncLiveTV
Dr. Taneja Discusses Imaging Techniques Used to Detect Metastatic Prostate Cancer
Samir Taneja, MD, James M. Neissa and Janet Riha Neissa professor of urologic oncology, vice chair, Department of Urology, professor, Department of ...
OncLiveTV
Intrathecal + IV nivo for metastatic melanoma with leptomeningeal disease
Sunandana Chandra, MD, MS, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, reviews data from a single-center Phase ...
VJOncology
Dr. Daniel George on Radium-223 in Combinations for Metastatic Castration-Resistant Prostate Cancer
Daniel J. George, MD, the director of GU Oncology at the Duke Cancer Institute, discusses the potential to incorporate radium-223 (Xofigo) into combination ...
OncLiveTV
When Breast Cancer is No Longer Curable - Mayo Clinic
Dr. Loprinzi reviews the goals of care and key discussion points for patients with a new diagnosis of stage IV (metastatic) breast cancer. To learn more about ...
Mayo Clinic
Upfront Therapy for Metastatic Colorectal Cancer
Tanios Bekaii-Saab, MD, discusses the case of a 64-year-old female patient with metastatic colorectal cancer and reviews the options for systemic therapy ...
Targeted Oncology
Guidelines for Early Detection of Metastasis in CRPC
Raoul S. Concepcion, MD, FACS; Phillip Koo, MD; and Alec Koo, MD, review guidelines for imaging patients to detect metastasis in castration-resistant prostate ...
OncLiveTV
Metastasis-Directed Therapy: Radiation Oncology Updates and Perspective
Steven E. Finkelstein, MD, FACRO, a radiation oncologist with Florida Cancer Affiliates in Panama City, Florida, discusses metastasis-directed therapy (MDT) as ...
Grand Rounds in Urology
Cabazitaxel (Jevtana) for Progressive Metastatic Prostate Cancer after Taxotere
If a man progresses after Taxotere chemotherapy, other options are still available. This video reviews the results with the FDA approved medication Cabazitaxel.
Gerald Chodak MD
Dr. Susan Slovin Reviews Immunotherapy Research in Prostate Cancer
Susan F. Slovin, MD, PhD, an associate member in the Genitourinary Oncology Service at the Memorial Sloan-Kettering Cancer Center, reviews the clinical ...
Targeted Oncology
Medical Update: HER2-Positive Metastatic Breast Cancer
About 20 percent of breast cancers are HER2 positive, testing positive for a protein called human epidermal growth factor receptor 2, or HER2. In this session ...
Living Beyond Breast Cancer
Novel Strategies for HER2+ Metastatic Breast Cancer; Biosimilars
Panelists Adam M. Brufsky, MD, PhD; Hope S. Rugo, MD; Ahmad Awada, MD, PhD; and Michael Untch, MD, provide insight on emerging novel strategies for ...
OncLiveTV
Introduction and Exploration of Fulvestrant in Metastatic Breast Cancer
Moderator, Adam M. Brufsky, MD, PhD, introduces the panel for an in-depth discussion analyzing recent trials that explored the detection, management, and ...
OncLiveTV
Case 4: OlympiAD Trial for BRCA+ Metastatic TNBC
Adam Brufsky, MD, PhD, reviews data from multiple clinical trials, including the phase 3 OlympiAD trial of olaparib versus chemotherapy in BRCA-positive ...
Targeted Oncology
Third-Line Therapy for Metastatic Colon Cancer
Michael A. Morse, MD, reviews the treatment options for third-line therapy in colon cancer, including how to choose the best therapy and manage the side effects ...
Targeted Oncology
